---
title: "Citi Keeps Their Buy Rating on AstraZeneca (AZN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298170107.md"
description: "In a report released today, Graham Parry from Citi maintained a Buy rating on AstraZeneca, with a price target of £178.00. According to TipRanks, Parry is a 2-star analyst with an average return of 0.4% and a 60.16% success rate. In addition to Citi, AstraZeneca also received a Buy from Berenberg Bank’s Luisa Hector in a report issued on September 2. However, on the same day, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN)."
datetime: "2026-09-07T05:35:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298170107.md)
  - [en](https://longbridge.com/en/news/298170107.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298170107.md)
generator: "portal-rs"
---

# Citi Keeps Their Buy Rating on AstraZeneca (AZN)

In a report released today, Graham Parry from Citi maintained a Buy rating on AstraZeneca, with a price target of £178.00.

According to TipRanks, Parry is a 2-star analyst with an average return of 0.4% and a 60.16% success rate.

In addition to Citi, AstraZeneca also received a Buy from Berenberg Bank’s Luisa Hector in a report issued on September 2. However, on the same day, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)
- [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md)
- [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md)

## Related News & Research

- [AstraZeneca: SERENA-4 Trial Of Etcamah Palbociclib Combination Fails To Meet Primary Objective](https://longbridge.com/en/news/298875452.md)
- [AstraZeneca: Buy Rating Reaffirmed on Robust Pipeline and Attractive Valuation; Price Target Unchanged at $16,500](https://longbridge.com/en/news/298918563.md)
- [AstraZeneca CFO Sarin gains 73 shares from 2021 performance share plan dividend equivalents](https://longbridge.com/en/news/299064766.md)
- [HB Wealth Management LLC Invests $4.90 Million in Astrazeneca Plc $AZN](https://longbridge.com/en/news/298284395.md)
- [Astrazeneca Plc (NYSE:AZN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages](https://longbridge.com/en/news/299278211.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**